A new risk factor indicator for papillary thyroid cancer based on immune infiltration

Increasing evidence has indicated a close association between immune infiltration in cancer and clinical outcomes. However, related research in thyroid cancer is still deficient. Our research comprehensively investigated the immune infiltration of thyroid cancer. Data derived from TCGA and GEO datab...

Full description

Saved in:
Bibliographic Details
Published in:Cell death & disease 2021-01, Vol.12 (1), p.51-51, Article 51
Main Authors: Yang, Zhou, Wei, Xiyi, Pan, Yitong, Xu, Jingyuan, Si, Yan, Min, Zhijun, Yu, Bo
Format: Article
Language:English
Subjects:
13/51
45/43
631/67/327
631/67/580
Algorithms
Antibodies
Biochemistry
Biomedical and Life Sciences
CD8 antigen
Cell Biology
Cell Culture
Endothelial cells
Fibroblasts
Immune checkpoint
Immunology
Immunotherapy
Infiltration
Life Sciences
Lymphocytes T
Medical prognosis
Papillary thyroid cancer
Risk factors
Stromal cells
Thyroid cancer
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c540t-49b0c56abfa927562a46f9a6687bac2e8c930e760fc3460bd50ff0408eb727b33
cites cdi_FETCH-LOGICAL-c540t-49b0c56abfa927562a46f9a6687bac2e8c930e760fc3460bd50ff0408eb727b33
container_end_page 51
container_issue 1
container_start_page 51
container_title Cell death & disease
container_volume 12
creator Yang, Zhou
Wei, Xiyi
Pan, Yitong
Xu, Jingyuan
Si, Yan
Min, Zhijun
Yu, Bo
description Increasing evidence has indicated a close association between immune infiltration in cancer and clinical outcomes. However, related research in thyroid cancer is still deficient. Our research comprehensively investigated the immune infiltration of thyroid cancer. Data derived from TCGA and GEO databases were analyzed by the CIBERSORT, ESTIMATE, and EPIC algorithms. The CIBERSORT algorithm calculates the proportions of 22 types of immune cells. ESTIMATE algorithm calculates a stromal score to represent all stromal cells in cancer. The EPIC algorithm calculates the proportions of cancer-associated fibroblasts (CAFs) and endothelial cells (ECs), which are the main components of stromal cells. We analyzed the correlation of immune infiltration with clinical characteristics and outcomes of patients. We determined that the infiltration of CD8 + T cells improved the survival of thyroid cancer patients. Overexpression of immune checkpoints was closely related to the development of thyroid cancer. In general, stromal cells were associated with the progression of thyroid cancer. Interestingly, CAFs and ECs had opposite roles in this process. In addition, the BRAF V600E mutation was related to the upregulation of immune checkpoints and CAFs and the downregulation of CD8 + T cells and ECs. Finally, we constructed an immune risk score model to predict the prognosis and development of thyroid cancer. Our research demonstrated a comprehensive panorama of immune infiltration in thyroid cancer, which may provide potential value for immunotherapy.
doi_str_mv 10.1038/s41419-020-03294-z
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4a86fb3055e641f69913162d63723829</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4a86fb3055e641f69913162d63723829</doaj_id><sourcerecordid>2476042088</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-49b0c56abfa927562a46f9a6687bac2e8c930e760fc3460bd50ff0408eb727b33</originalsourceid><addsrcrecordid>eNp9Uk1v1DAQjRCIVqV_gAOKxIVLYPxtX5Cqio9KlbjQs-U49tZLYi92QtX-erybUloOWLI88rz3PDN-TfMawXsERH4oFFGkOsDQAcGKdnfPmmMMFHVUSvX8UXzUnJayhboIAcz4y-aIkMqmII6bq7M2ups2h_Kj9cbOKbchDsGafeTr3pldGEeTb9v5-janMLTWROty25vihjbFNkzTEl2l-TDO2cwhxVfNC2_G4k7vz5Pm6vOn7-dfu8tvXy7Ozy47yyjMHVU9WMZN743CgnFsKPfKcC5Fbyx20ioCTnDwllAO_cDAe6AgXS-w6Ak5aS5W3SGZrd7lMNVCdTJBHy5S3miT52BHp6mR3PcEGHOcIs-VQgRxPHAiMJFYVa2Pq9Zu6Sc3WBdrM-MT0aeZGK71Jv3SQigETFaBd_cCOf1cXJn1FIp1dXjRpaVoTAVnTClKK_TtP9BtWnKsozqggGKQe0G8omxOpWTnH4pBoPcm0KsJdDWBPphA31XSm8dtPFD-fHkFkBVQaipuXP779n9kfwOXAryj</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2476042088</pqid></control><display><type>article</type><title>A new risk factor indicator for papillary thyroid cancer based on immune infiltration</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Yang, Zhou ; Wei, Xiyi ; Pan, Yitong ; Xu, Jingyuan ; Si, Yan ; Min, Zhijun ; Yu, Bo</creator><creatorcontrib>Yang, Zhou ; Wei, Xiyi ; Pan, Yitong ; Xu, Jingyuan ; Si, Yan ; Min, Zhijun ; Yu, Bo</creatorcontrib><description>Increasing evidence has indicated a close association between immune infiltration in cancer and clinical outcomes. However, related research in thyroid cancer is still deficient. Our research comprehensively investigated the immune infiltration of thyroid cancer. Data derived from TCGA and GEO databases were analyzed by the CIBERSORT, ESTIMATE, and EPIC algorithms. The CIBERSORT algorithm calculates the proportions of 22 types of immune cells. ESTIMATE algorithm calculates a stromal score to represent all stromal cells in cancer. The EPIC algorithm calculates the proportions of cancer-associated fibroblasts (CAFs) and endothelial cells (ECs), which are the main components of stromal cells. We analyzed the correlation of immune infiltration with clinical characteristics and outcomes of patients. We determined that the infiltration of CD8 + T cells improved the survival of thyroid cancer patients. Overexpression of immune checkpoints was closely related to the development of thyroid cancer. In general, stromal cells were associated with the progression of thyroid cancer. Interestingly, CAFs and ECs had opposite roles in this process. In addition, the BRAF V600E mutation was related to the upregulation of immune checkpoints and CAFs and the downregulation of CD8 + T cells and ECs. Finally, we constructed an immune risk score model to predict the prognosis and development of thyroid cancer. Our research demonstrated a comprehensive panorama of immune infiltration in thyroid cancer, which may provide potential value for immunotherapy.</description><identifier>ISSN: 2041-4889</identifier><identifier>EISSN: 2041-4889</identifier><identifier>DOI: 10.1038/s41419-020-03294-z</identifier><identifier>PMID: 33414407</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/51 ; 45/43 ; 631/67/327 ; 631/67/580 ; Algorithms ; Antibodies ; Biochemistry ; Biomedical and Life Sciences ; CD8 antigen ; Cell Biology ; Cell Culture ; Endothelial cells ; Fibroblasts ; Immune checkpoint ; Immunology ; Immunotherapy ; Infiltration ; Life Sciences ; Lymphocytes T ; Medical prognosis ; Papillary thyroid cancer ; Risk factors ; Stromal cells ; Thyroid cancer</subject><ispartof>Cell death &amp; disease, 2021-01, Vol.12 (1), p.51-51, Article 51</ispartof><rights>The Author(s) 2021</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-49b0c56abfa927562a46f9a6687bac2e8c930e760fc3460bd50ff0408eb727b33</citedby><cites>FETCH-LOGICAL-c540t-49b0c56abfa927562a46f9a6687bac2e8c930e760fc3460bd50ff0408eb727b33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2476042088/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2476042088?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25730,27900,27901,36988,36989,44565,53765,53767,75095</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33414407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Zhou</creatorcontrib><creatorcontrib>Wei, Xiyi</creatorcontrib><creatorcontrib>Pan, Yitong</creatorcontrib><creatorcontrib>Xu, Jingyuan</creatorcontrib><creatorcontrib>Si, Yan</creatorcontrib><creatorcontrib>Min, Zhijun</creatorcontrib><creatorcontrib>Yu, Bo</creatorcontrib><title>A new risk factor indicator for papillary thyroid cancer based on immune infiltration</title><title>Cell death &amp; disease</title><addtitle>Cell Death Dis</addtitle><addtitle>Cell Death Dis</addtitle><description>Increasing evidence has indicated a close association between immune infiltration in cancer and clinical outcomes. However, related research in thyroid cancer is still deficient. Our research comprehensively investigated the immune infiltration of thyroid cancer. Data derived from TCGA and GEO databases were analyzed by the CIBERSORT, ESTIMATE, and EPIC algorithms. The CIBERSORT algorithm calculates the proportions of 22 types of immune cells. ESTIMATE algorithm calculates a stromal score to represent all stromal cells in cancer. The EPIC algorithm calculates the proportions of cancer-associated fibroblasts (CAFs) and endothelial cells (ECs), which are the main components of stromal cells. We analyzed the correlation of immune infiltration with clinical characteristics and outcomes of patients. We determined that the infiltration of CD8 + T cells improved the survival of thyroid cancer patients. Overexpression of immune checkpoints was closely related to the development of thyroid cancer. In general, stromal cells were associated with the progression of thyroid cancer. Interestingly, CAFs and ECs had opposite roles in this process. In addition, the BRAF V600E mutation was related to the upregulation of immune checkpoints and CAFs and the downregulation of CD8 + T cells and ECs. Finally, we constructed an immune risk score model to predict the prognosis and development of thyroid cancer. Our research demonstrated a comprehensive panorama of immune infiltration in thyroid cancer, which may provide potential value for immunotherapy.</description><subject>13/51</subject><subject>45/43</subject><subject>631/67/327</subject><subject>631/67/580</subject><subject>Algorithms</subject><subject>Antibodies</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>CD8 antigen</subject><subject>Cell Biology</subject><subject>Cell Culture</subject><subject>Endothelial cells</subject><subject>Fibroblasts</subject><subject>Immune checkpoint</subject><subject>Immunology</subject><subject>Immunotherapy</subject><subject>Infiltration</subject><subject>Life Sciences</subject><subject>Lymphocytes T</subject><subject>Medical prognosis</subject><subject>Papillary thyroid cancer</subject><subject>Risk factors</subject><subject>Stromal cells</subject><subject>Thyroid cancer</subject><issn>2041-4889</issn><issn>2041-4889</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9Uk1v1DAQjRCIVqV_gAOKxIVLYPxtX5Cqio9KlbjQs-U49tZLYi92QtX-erybUloOWLI88rz3PDN-TfMawXsERH4oFFGkOsDQAcGKdnfPmmMMFHVUSvX8UXzUnJayhboIAcz4y-aIkMqmII6bq7M2ups2h_Kj9cbOKbchDsGafeTr3pldGEeTb9v5-janMLTWROty25vihjbFNkzTEl2l-TDO2cwhxVfNC2_G4k7vz5Pm6vOn7-dfu8tvXy7Ozy47yyjMHVU9WMZN743CgnFsKPfKcC5Fbyx20ioCTnDwllAO_cDAe6AgXS-w6Ak5aS5W3SGZrd7lMNVCdTJBHy5S3miT52BHp6mR3PcEGHOcIs-VQgRxPHAiMJFYVa2Pq9Zu6Sc3WBdrM-MT0aeZGK71Jv3SQigETFaBd_cCOf1cXJn1FIp1dXjRpaVoTAVnTClKK_TtP9BtWnKsozqggGKQe0G8omxOpWTnH4pBoPcm0KsJdDWBPphA31XSm8dtPFD-fHkFkBVQaipuXP779n9kfwOXAryj</recordid><startdate>20210106</startdate><enddate>20210106</enddate><creator>Yang, Zhou</creator><creator>Wei, Xiyi</creator><creator>Pan, Yitong</creator><creator>Xu, Jingyuan</creator><creator>Si, Yan</creator><creator>Min, Zhijun</creator><creator>Yu, Bo</creator><general>Nature Publishing Group UK</general><general>Springer Nature B.V</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210106</creationdate><title>A new risk factor indicator for papillary thyroid cancer based on immune infiltration</title><author>Yang, Zhou ; Wei, Xiyi ; Pan, Yitong ; Xu, Jingyuan ; Si, Yan ; Min, Zhijun ; Yu, Bo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-49b0c56abfa927562a46f9a6687bac2e8c930e760fc3460bd50ff0408eb727b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>13/51</topic><topic>45/43</topic><topic>631/67/327</topic><topic>631/67/580</topic><topic>Algorithms</topic><topic>Antibodies</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>CD8 antigen</topic><topic>Cell Biology</topic><topic>Cell Culture</topic><topic>Endothelial cells</topic><topic>Fibroblasts</topic><topic>Immune checkpoint</topic><topic>Immunology</topic><topic>Immunotherapy</topic><topic>Infiltration</topic><topic>Life Sciences</topic><topic>Lymphocytes T</topic><topic>Medical prognosis</topic><topic>Papillary thyroid cancer</topic><topic>Risk factors</topic><topic>Stromal cells</topic><topic>Thyroid cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Zhou</creatorcontrib><creatorcontrib>Wei, Xiyi</creatorcontrib><creatorcontrib>Pan, Yitong</creatorcontrib><creatorcontrib>Xu, Jingyuan</creatorcontrib><creatorcontrib>Si, Yan</creatorcontrib><creatorcontrib>Min, Zhijun</creatorcontrib><creatorcontrib>Yu, Bo</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Cell death &amp; disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Zhou</au><au>Wei, Xiyi</au><au>Pan, Yitong</au><au>Xu, Jingyuan</au><au>Si, Yan</au><au>Min, Zhijun</au><au>Yu, Bo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A new risk factor indicator for papillary thyroid cancer based on immune infiltration</atitle><jtitle>Cell death &amp; disease</jtitle><stitle>Cell Death Dis</stitle><addtitle>Cell Death Dis</addtitle><date>2021-01-06</date><risdate>2021</risdate><volume>12</volume><issue>1</issue><spage>51</spage><epage>51</epage><pages>51-51</pages><artnum>51</artnum><issn>2041-4889</issn><eissn>2041-4889</eissn><abstract>Increasing evidence has indicated a close association between immune infiltration in cancer and clinical outcomes. However, related research in thyroid cancer is still deficient. Our research comprehensively investigated the immune infiltration of thyroid cancer. Data derived from TCGA and GEO databases were analyzed by the CIBERSORT, ESTIMATE, and EPIC algorithms. The CIBERSORT algorithm calculates the proportions of 22 types of immune cells. ESTIMATE algorithm calculates a stromal score to represent all stromal cells in cancer. The EPIC algorithm calculates the proportions of cancer-associated fibroblasts (CAFs) and endothelial cells (ECs), which are the main components of stromal cells. We analyzed the correlation of immune infiltration with clinical characteristics and outcomes of patients. We determined that the infiltration of CD8 + T cells improved the survival of thyroid cancer patients. Overexpression of immune checkpoints was closely related to the development of thyroid cancer. In general, stromal cells were associated with the progression of thyroid cancer. Interestingly, CAFs and ECs had opposite roles in this process. In addition, the BRAF V600E mutation was related to the upregulation of immune checkpoints and CAFs and the downregulation of CD8 + T cells and ECs. Finally, we constructed an immune risk score model to predict the prognosis and development of thyroid cancer. Our research demonstrated a comprehensive panorama of immune infiltration in thyroid cancer, which may provide potential value for immunotherapy.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>33414407</pmid><doi>10.1038/s41419-020-03294-z</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2041-4889
ispartof Cell death & disease, 2021-01, Vol.12 (1), p.51-51, Article 51
issn 2041-4889
2041-4889
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4a86fb3055e641f69913162d63723829
source Publicly Available Content (ProQuest); PubMed Central; Springer Nature - nature.com Journals - Fully Open Access
subjects 13/51
45/43
631/67/327
631/67/580
Algorithms
Antibodies
Biochemistry
Biomedical and Life Sciences
CD8 antigen
Cell Biology
Cell Culture
Endothelial cells
Fibroblasts
Immune checkpoint
Immunology
Immunotherapy
Infiltration
Life Sciences
Lymphocytes T
Medical prognosis
Papillary thyroid cancer
Risk factors
Stromal cells
Thyroid cancer
title A new risk factor indicator for papillary thyroid cancer based on immune infiltration
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-25T02%3A51%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20new%20risk%20factor%20indicator%20for%20papillary%20thyroid%20cancer%20based%20on%20immune%20infiltration&rft.jtitle=Cell%20death%20&%20disease&rft.au=Yang,%20Zhou&rft.date=2021-01-06&rft.volume=12&rft.issue=1&rft.spage=51&rft.epage=51&rft.pages=51-51&rft.artnum=51&rft.issn=2041-4889&rft.eissn=2041-4889&rft_id=info:doi/10.1038/s41419-020-03294-z&rft_dat=%3Cproquest_doaj_%3E2476042088%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-49b0c56abfa927562a46f9a6687bac2e8c930e760fc3460bd50ff0408eb727b33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2476042088&rft_id=info:pmid/33414407&rfr_iscdi=true